Infective endocarditis prevention resident survival guide: Difference between revisions
Jump to navigation
Jump to search
Rim Halaby (talk | contribs) No edit summary |
Rim Halaby (talk | contribs) No edit summary |
||
Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{CMG}}; {{AE}} {{MM}}; {{ | {{CMG}}; {{AE}} {{MM}}; {{Rim}} | ||
==Overview== | ==Overview== |
Revision as of 15:14, 30 April 2014
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Mohamed Moubarak, M.D. [2]; Rim Halaby, M.D. [3]
Overview
Prevention
Shown below is an algorithm depicting the general prophylactic approaches of infective endocarditis.[1][2]
Identify high risk patients: (Class IIa, Level of evidence B)
❑ Prosthetic valves patients
| |||||||||
Identify high risk procedures:
❑ Respiratory tract procedures involving incision of the respiratory tract mucosa ❑ Gastrointestinal (GI) and genitourinary (GU) procedures only if GI or GU tract infection is present | |||||||||
❑ Administer prophylaxis
| |||||||||
Antibiotic Prophylaxis
Shown below is a table depicting the prophylaxis antibiotic regimes for infective endocarditis.[2]
|
References
- ↑ Wilson W, Taubert KA, Gewitz M, Lockhart PB, Baddour LM, Levison M; et al. (2007). "Prevention of infective endocarditis: guidelines from the American Heart Association: a guideline from the American Heart Association Rheumatic Fever, Endocarditis, and Kawasaki Disease Committee, Council on Cardiovascular Disease in the Young, and the Council on Clinical Cardiology, Council on Cardiovascular Surgery and Anesthesia, and the Quality of Care and Outcomes Research Interdisciplinary Working Group". Circulation. 116 (15): 1736–54. doi:10.1161/CIRCULATIONAHA.106.183095. PMID 17446442.
- ↑ 2.0 2.1 "2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: Executive Summary". Retrieved 4 March 2014.